Skip to main content

UTEP IBC Handbook

Introduction
Statement of Purpose
UTEP IBC Composition
Roles and Responsibilities
IBC Policies and Procedures
Submission Types
Review Types, Processes, and Timeline
Protocol Termination
Protocol Deviations and Allegations of Non-Compliance

IBC Policies and Procedures

 

General Guidelines 

The UTEP IBC typically conducts monthly meetings on the third Friday of each month, which are open to the public.  Advanced notice of these meetings is posted on the UTEP IBC website.  Protocols are approved for three years, and the IBC reviews initial and triennial submissions and procedural modifications. The PI will receive a formal letter via the institution submission platform, notifying them of the IBC's decision regarding all protocols. Except for the PI, personnel modifications are reviewed and approved administratively by the IBC analyst after training verification. 

Per the NIH Guidelines, the IBC Chair is responsible for submitting an annual report on IBC’s activities to the NIH OSP.  The report will include biographical sketches and details of each member and will be forwarded to NIH.  For any queries or information regarding IBC, individuals may contact the IBC Chair or IBC analyst. In case of a request for information under the Texas Public Information Act, the IBC analyst will provide the necessary information to the Vice President for Business Affairs Office (VPBA) for processing according to the regulations of the Texas State Attorney General's Office.  The IBC analyst will inform the IBC Chair, IO, and BSO about the request. 

All approved protocols will be valid for 3 years and will adhere to the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (refer to https://osp.od.nih.gov/wp-content/uploads/NIH_Guidelines.pdf).  The PI will receive a formal letter via the submission platform, notifying them of the IBC's decision regarding all protocols.